Prime Medicine closes $144.2 million public offering Aug 1, 2025 04:01PM
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares Aug 1, 2025 04:01PM
Prime Medicine Announces Pricing of Public Offering Jul 30, 2025 09:33PM
Prime Medicine announces public offering of common stock Jul 30, 2025 04:01PM
Prime Medicine Announces Proposed Public Offering of Common Stock Jul 30, 2025 04:01PM


Jul 30, 2025 04:01PM Prime Medicine Announces Proposed Public Offering of Common Stock
Dec 20, 2024 12:46PM BMO Capital Highlights Favorite Names for 2025 in Biotech
Oct 25, 2024 06:19AM BMO Capital Reiterates Outperform Rating on Prime Medicine (PRME)
Oct 4, 2024 07:19AM BMO Capital Reiterates Outperform Rating on Prime Medicine (PRME)
Oct 1, 2024 07:35AM BMO Capital Reiterates Outperform Rating on Prime Medicine (PRME)
Feb 20, 2024 04:01PM Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Feb 15, 2024 03:52AM Prime Medicine (PRME) Prices Upsized 19.2M Share Offering at $6.25/sh
Feb 14, 2024 11:50PM Prime Medicine Announces Pricing of Upsized Public Offering
Feb 14, 2024 04:05PM Prime Medicine (PRME) Announces Proposed $125M Share Offering
Feb 14, 2024 04:05PM Prime Medicine Announces Proposed Public Offering of Common Stock
Oct 9, 2023 05:49AM BMO Capital Starts Prime Medicine (PRME) at Outperform